A drug that treats corona in 5 days

pharmaceutical giant Merck and a US laboratory have made progress in developing an oral anti-Covid-19 drug.

According to Arabiya Net, the drug, which is still under trial, showed positive effects in reducing the viral load.

at the end of January, Merck stopped its work on developing two potential vaccines for Covid-19, but is continuing its research on two other treatments for the disease, one of which is the drug Molnopiravir it is developing in partnership with American Ridgepack Bayou.

During a meeting Saturday with specialists in infectious diseases, the drug's developers indicated that the drug significantly reduced patients' viral load after five days of treatment.

Ridgeback Bio's chief drug officer, Wendy Pinter, said in a statement that there was an unmet need for anti-SARS treatments. We are encouraged by these preliminary results.

Merck is also working on a treatment called mk-711. The group said at the end of January that first results from clinical trials showed a more than 50% reduction in the risk of death or respiratory failure in hospitalized patients with moderate to severe forms of Covid-19.